EPO Patents = 2

Trademarks = 1

Forward Citations = 3

Loading Chart...

12 inventors (with patents filed for the assignee):

Pan Zheng (7 out of 30 patents)

Martin Devenport (7 out of 13 patents)

Yang Liu (7 out of 33 patents)

4. Xuexiang Du (4 out of 4 patents)

5. Mingyue Liu (4 out of 6 patents)

6. Fei Tang (4 out of 4 patents)

7. Wei Wu (3 out of 27 patents)

8. Rhonda Flores (1 out of 1 patent)

9. Peiying Ye (1 out of 1 patent)

10. Zhihong Xue (1 out of 1 patent)

11. Hung-Yen Chou (1 out of 1 patent)

12. Yan Zhang (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12473362 - Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof (2025-11-18),

2. 12441780 - CD80 and CD86 binding protein compositions and uses thereof (2025-10-14),

3. 12286485 - Anti-CD24 compositions and uses thereof (2025-04-29),

4. 12227557 - CD80 and CD86 binding protein compositions and uses thereof (2025-02-18),

5. 12129299 - Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effects (2024-10-29),

6. 11629188 - Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof (2023-04-18),

7. 11261233 - CD80 and CD86 binding protein compositions and uses thereof (2022-03-01),

Company Overview

Oncoc4, Inc. is a biotechnology company specializing in the development of innovative cancer therapies. The company focuses on the discovery and advancement of novel compounds that target cancer cell metabolism and signaling pathways, aiming to improve treatment outcomes for patients. With a team of experienced scientists and industry experts, Oncoc4, Inc. is committed to transforming cancer care through research, collaboration, and clinical development. The company's lead product candidates are currently in various stages of preclinical and clinical trials, demonstrating potential for significant therapeutic benefits. Oncoc4, Inc. is dedicated to addressing unmet needs in oncology and advancing the frontiers of cancer treatment through precision medicine and targeted therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#88 in Rockville, MD

#569 in Maryland

#39,929 in US

Rockville, MD, United States of America

Oncoc4, Inc.

Forward Citations = 3

12 inventors:

Pan Zheng (7 out of 30 patents)

Martin Devenport (7 out of 13 patents)

Yang Liu (7 out of 33 patents)

4. Xuexiang Du (4 out of 4 patents)

5. Mingyue Liu (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncoc4, Inc.. Retrieved from https://idiyas.com/company/oncoc4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]